secwatch.observer — SEC 8-K summary
======================================

Issuer:     Theravance Biopharma, Inc. (TBPH)
CIK:        0001583107
Form:       8-K
Filed at:   2024-09-10T23:59:59+00:00
Accession:  0001104659-24-098326
Event type: other
Sentiment:  neutral
Materiality: 0.00
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Theravance Biopharma presents at H.C. Wainwright conference; no material financial updates in slide deck
--------------------------------------------------------------------------------

- Management team to participate in fireside chat and one-on-one meetings at H.C. Wainwright 26th Annual Global Investment Conference on September 10, 2024.
- Slide presentation furnished as Exhibit 99.1 contains no new financial guidance or operational data beyond prior disclosures.
- Filing is a procedural Regulation FD disclosure for investor presentation; no earnings, M&A, or leadership changes announced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1583107/000110465924098326/0001104659-24-098326-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1583107/000110465924098326/tm2423596d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-098326

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer